Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 3 2Phase 2 1

Status

Completed 3Recruiting 2Terminated 1

Sponsor Class

OTHER 16INDUSTRY 6NIH 3OTHER_GOV 2NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Lymphoid 6

Conditions

Lymphoma, Large B-Cell, Diffuse 31Lymphoma, Non-Hodgkin 20Lymphoma, Follicular 19Lymphoma 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, B-Cell 11Neoplasms 10Recurrence 8Lymphoma, Mantle-Cell 7Lymphoma, T-Cell, Peripheral 6Leukemia 5Hematologic Diseases 5Sarcoma, Kaposi 3Neuroblastoma 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3HIV Infections 3Acquired Immunodeficiency Syndrome 3Wilms Tumor 2Small Cell Lung Carcinoma 2Multiple Myeloma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphatic Diseases 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Burkitt Lymphoma 2Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1

Interventions

10-propargyl-10-deazaaminopterin 12Cyclophosphamide 8Prednisone 7belinostat 6Vincristine 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Doxorubicin 6Brentuximab Vedotin 5romidepsin 4mogamulizumab 4darinaparsin 4Vitamin B 12 4Gemcitabine 4Folic Acid 4selinexor 3denileukin diftitox 3Nivolumab 3Injections 3Bendamustine Hydrochloride 3tislelizumab 2tipifarnib 2tenalisib 2duvelisib 2Rituximab 2Lenalidomide 2HBI-8000 2Fenretinide 2E7777 fusion protein 2AFM13 2venetoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Lymphoma, T-Cell, Peripheral × Vincristine × Clear all
NCT06072131 2025-10-23

CRESCENDO

Acrotech Biopharma Inc.

Phase 3 Recruiting
504 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT06947967 2025-09-15

Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Chipscreen Biosciences, Ltd.

Phase 3 Recruiting
224 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT04548700 2024-03-07

Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCL

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Terminated
38 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT00211185 2020-03-18

A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma

Eisai Inc.

Phase 2 Completed
49 enrolled 11 charts
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT01839097 2020-01-03

Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)

Acrotech Biopharma Inc.

Phase 1 Completed
23 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT02809573 2019-07-24

Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients

Chipscreen Biosciences, Ltd.

Phase 1 Completed
30 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡